Skip to main content
. 2015 Jan 31;2015:571836. doi: 10.1155/2015/571836

Table 2.

Zone of inhibition (mm) of the synthesized compounds.

Compounds Zone of inhibition (mm)#
Gram positive bacteria Gram negative bacteria Fungal strains
B. subtilis B. cereus S. epidermidis S. aureus E. coli K. pneumoniae P. mirabilis P. aeruginosa C. albicans C. tropicalis
4a 18.6 16.5 14.0 16.0 11.8 16.0
4b 12.8 11.0
4c 14.6 16.8 18.4 18.4 17.8 21.8 19.4
4d 22.4 19.6 17.4 20.2 10.4
4e 14.5 15.4 16.0
4f 14.8 14.8
4g 15.3 18.4 20.0 17.0 17.6 18.2 22.2 14.8
4h 24.3 20.8 19.6 22.4 15.6 14.0 15.0 17.0 15.0
4i 15.4 13.5 12.0
4j 18.1 12.4 19.2 16.8 11.6 18.0
4k 11.6 10.6 20.6 19.6 17.4 18.8
4l 11.0 9.8 10.2 10.8
4m 17.0 18.0 20.0 12.0
4n 18.8 17.4 20.4 19.6 22.8 20.0 18.2 20.1 21.4
4o 11.4 13.0 11.2 10.2
Ciprofloxacin 25.4 23.5 21.0 26.0 25.0 24.7 20.2 21.0 NT NT
Fluconazole NT NT NT NT NT NT NT NT 25.0 24.6

#Average of three determinations; NT: not tested; — indicates no inhibition.

HHS Vulnerability Disclosure